These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21349547)

  • 1. Re: Smaller prostate size predicts high grade prostate cancer at final pathology. M. R. Newton, S. Phillips, S. S. Chang, P. E. Clark, M. S. Cookson, R. Davis, J. H. Fowke, S. D. Herrell, R. Baumgartner, R. Chan, V. Mishra, J. D. Blume, J. A. Smith, Jr. and D. A. Barocas. J Urol 2010; 184: 930-937.
    Calışkan S
    J Urol; 2011 Apr; 185(4):1537-8; author reply 1538. PubMed ID: 21349547
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy. J. A. Smith, Jr., R. C. Chan, S. S. Chang, S. D. Herrell, P. E. Clark, R. Baumgartner and M. S. Cookson. J Urol 2007; 178: 2385-2390.
    Canes D
    J Urol; 2008 Jul; 180(1):410-1; author reply 411. PubMed ID: 18499156
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy: J. A. Smith, Jr., R. C. Chan, S. S. Chang, S. D. Herrell, P. E. Clark, R. Baumgartner and M. S. Cookson. J Urol 2007; 178: 2385-2390.
    Masieri L; Minervini A; Serni S; Carini M
    J Urol; 2008 Nov; 180(5):2257; author reply 2257. PubMed ID: 18823916
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. C. J. Stimson, M. S. Cookson, D. A. Barocas, P. E. Clark, J. E. Humphrey, S. G. Patel, J. A. Smith, Jr. and S. S. Chang. J Urol 2010; 183: 1732-1737.
    Neulander EZ; Katz T; Yusim I; Kaneti J
    J Urol; 2011 Apr; 185(4):1536-7. PubMed ID: 21334665
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Recovery of urinary function after radical prostatectomy: identification of trajectory cluster groups: C. B. Anderson, M. R. Kaufman, M. S. Dietrich, D. A. Barocas, S. S. Chang, M. S. Cookson, J. A. Smith, Jr., P. E. Clark and S. D. Herrell J Urol 2012; 187: 1346-1351.
    Namiki S; Arai Y
    J Urol; 2013 Jan; 189(1):394-5. PubMed ID: 23174260
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. S. J. Freedland, E. A. Platz, J. C. Presti Jr., W. J. Aronson, C. L. Amling, C. J. Kane and M. K. Terris. J Urol, 175: 500-504, 2006.
    Stamatiou K; Alevizos A; Mariolis A; Sofras F
    J Urol; 2006 Sep; 176(3):1251-2; author reply 1252. PubMed ID: 16890735
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Ureteroenteric anastomotic strictures after radical cystectomy--does operative approach matter?: C. B. Anderson, T. M. Morgan, S. Kappa, D. Moore, P. E. Clark, R. Davis, D. F. Penson, D. A. Barocas, J. A. Smith, Jr., M. S. Cookson and S. S. Chang. J Urol 2013; 189: 541-547.
    Skinner DG
    J Urol; 2013 Jul; 190(1):362-3. PubMed ID: 23416635
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy I. M. Thompson, C. M. Tangen, D. P. Ankerst, C. Chi, M. S. Lucia, P. Goodman, H. Parnes and C. A. Coltman, Jr. J Urol 2008; 180: 544-547.
    Atmaca AF; Balbay MD
    J Urol; 2009 May; 181(5):2387-8. PubMed ID: 19303084
    [No Abstract]   [Full Text] [Related]  

  • 9. Smaller prostate size predicts high grade prostate cancer at final pathology.
    Newton MR; Phillips S; Chang SS; Clark PE; Cookson MS; Davis R; Fowke JH; Herrell SD; Baumgartner R; Chan R; Mishra V; Blume JD; Smith JA; Barocas DA
    J Urol; 2010 Sep; 184(3):930-7. PubMed ID: 20643423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. A. J. Stephenson, D. P. Wood, M. W. Kattan, E. A. Klein, P. T. Scardino, J. A. Eastham and B. S. Carver j urol 2009; 182: 1357-1363.
    Calışkan S; Kaya C
    J Urol; 2011 Mar; 185(3):1155. PubMed ID: 21256516
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer. S. T. dos Reis, J. Pontes, Jr., F. E. Villanova, P. M. D. Borra, A. A. Antunes, M. F. Dall'oglio, M. Srougi and K. R. M. Leite. J Urol 2009; 181: 2320-2325.
    Ahirwar DK; Mittal RD
    J Urol; 2010 Mar; 183(3):1258. PubMed ID: 20097381
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer. J. B. Malcolm, M. D. Fabrizio, B. B. Barone, R. W. Given, R. S. Lance, D. F. Lynch, J. W. Davis, M. E. Shaves and P. F. Schellhammer. J Urol 2010; 183: 1822-1828.
    Parker AS
    J Urol; 2011 May; 185(5):1983-4. PubMed ID: 21439591
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: prostate specific antigen decrease and prostate cancer diagnosis: antibiotic versus placebo prospective randomized clinical trial: R. M. Stopiglia, U. Ferreira, M. M. Silva, W. E. Matheus, f. Denardi and L. O. Reis J Urol 2010; 183: 940-945.
    Yoon DK; Park HS; Park JY
    J Urol; 2010 Nov; 184(5):2214-5; author reply 2215. PubMed ID: 20864135
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies: R. Abouassaly, N. Tan, A. Moussa and J. S. Jones J Urol 2008; 180: 911-914.
    Feldstein MS; Hentz JG
    J Urol; 2009 Apr; 181(4):1960-1; author reply 1961. PubMed ID: 19251278
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features: R. J. Cohen, B. A. Shannon, M. Phillips, R. E. Moorin, T. M. Wheeler and K. L. Garrett J Urol 2008; 179: 1762-1767.
    Mai KT; Veinot JP
    J Urol; 2008 Dec; 180(6):2714; author reply 214-5. PubMed ID: 18951578
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Validation of the Partin nomogram for prostate cancer in a national sample: J. B. Yu, D. V. Makarov, R. Sharma, R. E. Peschel, A. W. Partin and C. P. Gross J Urol 2010; 183: 105-111.
    Ozcan MF; Akbulut Z; Canda AE; Kilic M; Duran E; Balbay MD
    J Urol; 2010 Oct; 184(4):1571-2; author reply 1572-3. PubMed ID: 20732697
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Small prostate size and high grade disease--biology or artifact?: J. J. Liu, J. D. Brooks, M. Ferrari, R. Nolley and J. C. Presti, Jr. J Urol 2011; 185: 2108-2111.
    Calışkan S
    J Urol; 2011 Dec; 186(6):2504; author reply 2504-5. PubMed ID: 22019038
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: A multi-institutional evaluation of active surveillance for low risk prostate cancer. S. E. Eggener, A. Mueller, R. K. Berglund, R. Ayyathurai, C. Soloway, M. S. Soloway, R. Abouassaly, E. A. Klein, S. J. Jones, C. Zappavigna, L. Goldenberg, P. T. Scardino, J. A. Eastham and B. Guillonneau J Urol 2009; 181: 1635-1641.
    Ayres BE; Bott SR; Barber NJ; Langley SE; Montgomery BS
    J Urol; 2010 Sep; 184(3):1223-4; author reply 1224. PubMed ID: 20655069
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy: C. Von Bodman, G. Godoy, D. C. Chade, A. Cronin, L. J. Tafe, S. W. Fine, V. Laudone, P. T. Scardino and J. A. Eastham J Urol 2010; 184: 143-148.
    Cai T; Nesi G; Malossini G; Bartoletti R
    J Urol; 2011 Jan; 185(1):360-1; author reply 361. PubMed ID: 21092995
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial I. M. Thompson, C. M. Tangen, J. Paradelo, M. S. Lucia, G. Miller, D. Troyer, E. Messing, J. Forman, J. Chin, G. Swanson, E. Canby-Hagino and E. D. Crawford J Urol 2009; 181: 956-962.
    Cheng T; Heng DY; Stewart D
    J Urol; 2009 Nov; 182(5):2531-2; discussion 2532-4. PubMed ID: 19766252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.